SB 1765
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| California Public Interest Research Group, Inc. | Lobbied on it | California Public Interest Research Group, Inc. named SB 1765 in 4 lobbying reports. | 4 reports |
| GSK | Lobbied on it | GSK named SB 1765 in 3 lobbying reports. | 3 reports |
| Schering Corporation | Lobbied on it | Schering Corporation named SB 1765 in 3 lobbying reports. | 3 reports |
| Wyeth | Lobbied on it | Wyeth named SB 1765 in 3 lobbying reports. | 3 reports |
| Abbott Laboratories | Lobbied on it | Abbott Laboratories named SB 1765 in 2 lobbying reports. | 2 reports |
| Allergan, Inc. and Its Affiliates | Lobbied on it | Allergan, Inc. and Its Affiliates named SB 1765 in 2 lobbying reports. | 2 reports |
| Amgen | Lobbied on it | Amgen named SB 1765 in 2 lobbying reports. | 2 reports |
| Daiichi Sankyo Inc. | Lobbied on it | Daiichi Sankyo Inc. named SB 1765 in 2 lobbying reports. | 2 reports |
| Pharmaceuticals: marketing practices. | Source records | SB 1765 has an explicit source reference to Pharmaceuticals: marketing practices.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…

